How have we been lending a hand to the COVID-19 effort?
June 9, 2020

COVID-19 is undoubtedly having an impact on patient populations. During this challenging time, Talking Medicines have been doing their bit to support the Medsmart® community whilst sharing data insight from greater patient populations to add value to Government data, to help others and raise awareness of the work we are doing.

COVID-19 Tracker

The UK statistics show that there are 15,639 confirmed cases of COVID-19 in Scotland and 155,000, 14,438 and 4,802 in England, Wales and Northern Ireland respectively (The Guardian). To play our part in tracking and to support our Medsmart® community we created a new version of our App – inclusive of a COVID-19 tracker. So far we have had an uptake of 2.82% across our Medsmart® community with a proportion of users confirming that they have tested positive for COVID-19, another group that think they may have COVID-19 and a further subset of users that are using this feature to state that they are unaffected. We are delighted to that there is use of the tracker already and intend to keep this feature in the App over the coming months to support users and add value to coronavirus data as time goes on. The profile of those experiencing symptoms are expressed in the infographic below:

Tracking impact of the pandemic on medicines uploaded to Medsmart®

We have also been looking at the medicines being scanned into our Medsmart® App over the last few months. We can see that over the course of the pandemic the top five medicines uploaded were: Omeprazole, levothyroxine, sertraline, atorvastatin and Ramipril. These drugs are used to treat gastric acid, hypothyroidism, depression, high cholesterol and high blood pressure respectively.

We believe that the data we collect about how people talk about their health and use their medicines can be used for good. It is important to us that we use our tools not only to connect patients with the wider healthcare system but also to connect the healthcare system back to the patients and their voices. We hope that by continuing to collate and structure data from our COVID-19 Tracker and by analysing changes in user medicine uploads we can continue to contribute to the COVID-19 effort as it enters this new “test and trace” phase.

 

Ref: https://www.theguardian.com/world/2020/jun/09/coronavirus-uk-map-the-latest-deaths-and-confirmed-cases-near-you

Recent Blogs

COVID-19 – The catalyst changing our health behaviour

COVID-19 – The catalyst changing our health behaviour

We are in a period of limbo, having apparently weathered phase one of the Corona Virus wave. Now as autumn arrives we are bracing to see if we can avoid another peak over winter. Many of our past activities have resumed; we are back in bars, restaurants, gyms and...

Counterfeit medicines in Africa

Counterfeit medicines in Africa

What is a counterfeit medicine? A counterfeit medicine is a medical product which is substandard or falsified and therefore hasn’t undergone evaluation by any regulatory authority before making it to the correct patients. The WHO estimate that 10% of all medicines in...

Why does ‘Feelings Data’ matter to us?

Why does ‘Feelings Data’ matter to us?

We live in a world in which “feelings” symptoms carry far less gravitas than those that are physical. Though physical traits will always be paramount in disease tracking and treatment, we have realised that acknowledging how patients feel is just as important. Why is...